Aurinia Pharmaceuticals, Inc. (AUPH)

15.57 +0.29 (+1.90%) USD  |  NASDAQ  |  May 18, 13:16
More

Aurinia Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for AUPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Xenon Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
ProMIS Neurosciences, Inc. Upgrade
Medicus Pharma Ltd. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade